Moreover, recent reports have shown that the expression of SIRT1 is associated with a poor prognosis in specific human tumors including hepatocellular carcinoma [14], gastric cancer [15], breast cancer [16], and diffuse large B cell lymphoma [17]. Here, SIRT1 is linked to breast carcinoma.